Boxing Belide Chemical Co., Ltd. is a company specializing in 2.3.4 trimethoxybenzaldehyde DA-6、 A company specializing in the production and processing of products such as 2-amino-4,6-dimethoxypyrimidine, resveratrol, triethylamine, thioacetic acid, p-nitrophenylacetonitrile, p-aminophenylacetonitrile, 2-chloronicotinic acid, p-hydroxyphenylacetonitrile, 34 dimethoxybenzaldehyde, 3.4 dimethoxybenzoic acid, dicyanopyridine, 24 dimethoxybenzaldehyde, etc. It has a complete and scientific quality management system. The integrity, strength, and product quality of Boxing Beilide Chemical Co., Ltd. have been recognized by the industry. Welcome friends from all walks of life to visit, guide and negotiate business.
    On September 7, 2011, the company was renamed from the original Boxing County Jiayan Chemical Co., Ltd. The company covers an area of 23370m2 and is located in the eastern area of Jingbo Industrial Zone, Chenhu Town, Boxing County. It is a professional enterprise engaged in the production of pharmaceutical intermediates and pesticide intermediates, mainly producing pharmaceutical intermediates p-nitrophenylacetonitrile, p-aminophenylacetonitrile, and pesticide intermediates 2-chloronicotinic acid and pyrimethanil. The company invested 1.8 million yuan to build a comprehensive production workshop and related supporting facilities. The company currently has 21 employees and has established technical cooperation relationships with multiple research institutions such as Zhejiang University and Zhejiang University of Technology. We engage in extensive technical and information exchanges with them in order to continuously develop new products that are at the forefront of domestic and international markets and meet the demand for medical and chemical products. The company's technical center strictly monitors product quality, with complete testing equipment, precision testing instruments such as high-performance liquid chromatography and gas chromatography, a complete analysis and testing system, and a strict quality testing system.
      After the company was registered and renamed in 2011, it made a series of changes and adjustments to its business direction and product structure based on the actual market situation. The company also made a series of improvements to its existing facilities and introduced advanced process equipment, eliminating some facilities and equipment that did not meet the current development status of the enterprise. Nearly 500000 yuan was newly invested to renovate the existing facilities and equipment, in order to better suit the development of the enterprise and upgrade its products, laying a foundation for creating greater economic and social benefits for the enterprise. The company mainly carried out renovation and improvement of existing facilities in 2011, without carrying out workshop production, laying the foundation for production in 2012.
      The company conducted a series of investigations on the pharmaceutical and pesticide intermediate markets in 2012, and formulated a development plan for the company. In 2012, the company mainly focused on the pharmaceutical and pesticide intermediate markets, selecting products suitable for the company's development, and mainly producing marketable products such as pharmaceutical intermediate p-aminophenylacetonitrile, pesticide intermediate 2-chloronicotinic acid, and pyrimethanil. The plan is to produce 50 tons of p-aminophenylacetonitrile, 50 tons of 2-chloronicotinic acid, and 50 tons of pyrimethanil, achieving sales of 25 million yuan and profits and taxes of more than 3 million yuan.
      In the next five years, based on the current market situation, the overall pharmaceutical intermediate market is showing a growing trend. On the basis of stabilizing the production of pesticide intermediates 2-chloronicotinic acid and pyrimidine amine, the company plans to increase investment in pharmaceutical intermediates, with a focus on strengthening production investment in pharmaceutical intermediates. The demand for pharmaceutical intermediates is rapidly increasing, especially high-end pharmaceutical and dye intermediates, which have great market potential. We plan to develop cardiovascular drug intermediates 3,4-dimethoxybenzaldehyde, 3,4-dimethoxybenzoic acid, 2,3,4-trimethoxybenzaldehyde, and 2,4-dimethoxybenzaldehyde for technological research and industrial application, in order to improve the overall technical level of the enterprise and lay the foundation for its later development. The company adopts advanced professional technology and scientific management methods, based on the domestic market and relying on international technology, to formulate and sell high-end pharmaceutical and dye intermediates that meet China's national conditions, and can obtain good social and economic benefits.